Last reviewed · How we verify
NCT04438109
Clinical Outcome of the Dynamic Reconstruction of the Medial Patellofemoral Ligament (MPFL)
trial in Patellar Luxation in 152 participants. Completed in 27 February 2021.
12 April 2019
Quick facts
| Lead sponsor | Hannover Medical School |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 152 |
| Start date | 12 April 2019 |
| Primary completion | 12 April 2019 |
| Estimated completion | 27 February 2021 |
| Sites | 1 location across Germany |
Conditions studied
- Patellar Luxation — all drugs for Patellar Luxation →
- Patellar Instability — all drugs for Patellar Instability →
Sponsor
Hannover Medical School
Who can join
18 and older, any sex, with Patellar Luxation or Patellar Instability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In a single surgical center, 213 consecutive patients with 221 knees were surgically treated for recurrent lateral patellar dislocation between 07/2010 and 12/2016. All patients obtained dynamic reconstruction of the MPFL with detachment of the gracilis tendon at the pes anserinus while maintaining the proximal origin at the gracilis muscle. Patellar fixation was performed by oblique transpatellar tunnel transfer and tenodesis screw. Follow-up data including Kujala-, BANFF- and Norwich patellar instability score as well as Return-to-Sport and pain level were collected at a minimum follow-up of 2 years
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The novel dynamic MPFL-reconstruction technique: cheaper and better?
Horstmann H, Karkosch R, Berg A, Becher C, et al · · 2022 · cited 9× · PMID 34633513 · DOI 10.1007/s00402-021-04198-z
Verify or expand the search:
- PubMed search for NCT04438109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hannover Medical School trials
Trials by the same sponsor.
- NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
- NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
- NCT06795516 — Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation · terminated
- NCT06603311 — Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of · NA · active not recruiting
- NCT06493006 — Promoting Sustainable and Active Mobility Among Employees and Students · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04438109 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hannover Medical School
- Last refreshed: 19 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing